Spetzler David Baxley

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -22% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 4%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Spetzler David Baxley's trades of Caris Life Sciences, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
23.85
Quantity 400 +0.1%
Value US$9,540
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-04
S Sale
1,212 -29.9%
127.80
US$2,059,246 		1,212 -29.9% 127.80 US$2,059,246
2026-09-04 2026-09-04
PrS Proposed sale
24,221
344.09
US$2,220,541 		24,221 344.09 US$2,220,541
2026-09-04 2026-09-03
S Sale
30,823 -7.6%
290.82
US$1,707,108 		30,823 -7.6% 290.82 US$1,707,108
2026-09-04 2026-09-03
S Sale
393,100 -25.7%
24.76
US$9,733,313 		393,100 -25.7% 24.76 US$9,733,313
2026-09-03 2026-09-03
PrS Proposed sale
478,000
24.86
US$11,882,984 		478,000 24.86 US$11,882,984
2025-11-10 2025-11-07
B Purchase
400 +0.1%
23.85
US$9,540 		400 +0.1% 23.85 US$9,540